Premature ejaculation (PE) may be a common male sexual disorder. Recent normative data suggests that men with an intravaginal ejaculatory latency time (IELT) of but 1 minute have “definite” PE, while men with IELTs between 1 and 1.5 minutes have “probable” PE. Although there's insufficient empirical evidence to spot the etiology of PE, there's limited correlational evidence to suggest that men with PE have high levels of sexual anxiety and inherited altered sensitivity of central 5-HT (5-hydroxytryptamine, serotonin) receptors. Pharmacological modulation of the ejaculatory threshold using off-label daily or on-demand selective serotonin re-uptake inhibitors is well tolerated and offers patients a high likelihood of achieving improved ejaculatory control within a couple of days of initiating treatment, consequential improvements in concupiscence and other sexual domains. Investigational drugs like the ejaculo-selective serotonin transport inhibitor, dapoxetine represent a serious development in sexual medicine.
Research Article: International Journal of Public Health and Safety
Research Article: International Journal of Public Health and Safety
Research Article: International Journal of Public Health and Safety
Research Article: International Journal of Public Health and Safety
Posters & Accepted Abstracts: Journal of Nursing & Care
Posters & Accepted Abstracts: Journal of Nursing & Care
Posters & Accepted Abstracts: Journal of Nursing & Care
Posters & Accepted Abstracts: Journal of Nursing & Care
Scientific Tracks Abstracts: Journal of Nursing & Care
Scientific Tracks Abstracts: Journal of Nursing & Care
Scientific Tracks Abstracts: Journal of Nursing & Care
Scientific Tracks Abstracts: Journal of Nursing & Care
Posters & Accepted Abstracts: Journal of Nursing & Care
Posters & Accepted Abstracts: Journal of Nursing & Care